COVID-19 driving adoption of virtual trials
5 Promising Covid-19 Vaccines Picked For Trump’s Operation Warp Speed
Scientists tap the world's most powerful computers in the race to understand and stop the coronavirus
LabCorp Launches Website to Connect Patients with COVID-19 Clinical Trials
Study panning anti-malaria drug Trump took against COVID faces new questions
HCQ Misinformation Can Be Deadly: Let Patients Decide
Study finds COVID-19 convalescent plasma therapy safe, with 76% patients improving
Antibody injections could fight COVID-19 infections – an infectious disease expert explains the prospects
From the research lab to your doctor's office – here's what happens in phase 1, 2, 3 drug trials
Convenient spit test helps women assess cancer risk from the comfort of their own homes
Drugmaker Abbvie Teams Up With Jacobio To Develop Cancer Inhibitor
Exclusive: Sanofi stops enrolling COVID-19 patients in hydroxychloroquine trials
How the coronavirus could be prevented from invading a host cell
Atriva takes MEK inhibitor into phase 2 for COVID-19
Novavax (NVAX) Stock Is a Winner, But How Much Higher Can It Go?
Oxford Biomedica signs COVID-19 vaccine supply deal with AZ
AstraZeneca may consider exposing vaccine trial participants to virus
Cincinnati children’s HLH research points to treatment for COVID-19 cytokine storms
PKU-led team found effective SARS-CoV-2 neutralizing antibodies
GSK to produce a billion doses of COVID-19 vaccine booster by 2021
ABPI’s Sheuli Porkess on how COVID-19 could improve clinical trial conduct
Vaxine and Medytox – COVAX-19®
France, Italy, Belgium act to stop use of hydroxychloroquine for COVID-19 on safety fears
Merck CEO Casts Doubt On ‘Very Aggressive’ Covid-19 Vaccine Timeline
UK okays early access to Gilead’s remdesivir in seriously ill COVID-19 patients
Merck & Co and IAVI join forces to develop COVID-19 vaccine
Promising pre-clinical results for USask VIDO-InterVac COVID-19 vaccine
Eli Lilly, Junshi Biosciences To Start Human Testing Of Covid-19 Antibodies By Q2
Merck Takes 3 Major Shots at COVID-19
Some patients with bladder cancer ‘can’t wait’ for treatment during the COVID-19 pandemic